Eldad J. Dann
Department of Hematology and Bone Marrow Transplantation
Rambam Health Care Campus
8, Ha'Aliya Street
Haifa
Israel
Name/email consistency: high
- PET/CT adapted therapy in Hodgkin disease: current state of the art and future directions. Dann, E.J. Curr. Oncol. Rep (2012)
- A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved. Dann, E.J., Blumenfeld, Z., Bar-Shalom, R., Avivi, I., Ben-Shachar, M., Goor, O., Libster, D., Gaitini, D., Rowe, J.M., Epelbaum, R. Am. J. Hematol. (2012)
- Transfusion medicine during the summer of 2006: lessons learned in northern Israel. Dann, E.J., Michaelson, M., Barzelay, M., Hoffman, R., Bonstein, L. Transfus. Med. Rev (2008)
- Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome. Dann, E.J., Bar-Shalom, R., Tamir, A., Haim, N., Ben-Shachar, M., Avivi, I., Zuckerman, T., Kirschbaum, M., Goor, O., Libster, D., Rowe, J.M., Epelbaum, R. Blood (2007)
- Blood bank protocols for large-scale civilian casualty events: experience from terrorist bombing in Israel. Dann, E.J., Bonstein, L., Arbov, L., Kornberg, A., Rahimi-Levene, N. Transfus. Med (2007)
- Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma. Dann, E.J., Epelbaum, R., Avivi, I., Ben Shahar, M., Haim, N., Rowe, J.M., Blumenfeld, Z. Hum. Reprod. (2005)









